HK1048321B - 新的氨基丙基次膦酸 - Google Patents
新的氨基丙基次膦酸Info
- Publication number
- HK1048321B HK1048321B HK03100457.3A HK03100457A HK1048321B HK 1048321 B HK1048321 B HK 1048321B HK 03100457 A HK03100457 A HK 03100457A HK 1048321 B HK1048321 B HK 1048321B
- Authority
- HK
- Hong Kong
- Prior art keywords
- new
- aminopropylphosphinic acids
- acids
- new aminopropylphosphinic
- aminopropylphosphinic
- Prior art date
Links
- ZTHNRNOOZGJLRR-UHFFFAOYSA-N chembl112203 Chemical class NCCCP(O)=O ZTHNRNOOZGJLRR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
- C07F9/4808—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
- C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904508A SE9904508D0 (sv) | 1999-12-09 | 1999-12-09 | New compounds |
| SE0003640A SE0003640D0 (sv) | 2000-10-09 | 2000-10-09 | New compounds |
| PCT/SE2000/002426 WO2001042252A1 (en) | 1999-12-09 | 2000-12-04 | New aminopropylphosphinic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1048321A1 HK1048321A1 (en) | 2003-03-28 |
| HK1048321B true HK1048321B (zh) | 2005-09-30 |
Family
ID=26655259
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK03100457.3A HK1048321B (zh) | 1999-12-09 | 2003-01-17 | 新的氨基丙基次膦酸 |
| HK03105473A HK1053125A1 (en) | 1999-12-09 | 2003-07-29 | New aminopropylphosphinic acids. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK03105473A HK1053125A1 (en) | 1999-12-09 | 2003-07-29 | New aminopropylphosphinic acids. |
Country Status (33)
| Country | Link |
|---|---|
| US (5) | US6576626B2 (zh) |
| EP (2) | EP1484333A1 (zh) |
| JP (2) | JP3914435B2 (zh) |
| KR (1) | KR100689144B1 (zh) |
| CN (1) | CN1198832C (zh) |
| AR (1) | AR030541A1 (zh) |
| AT (1) | ATE282043T1 (zh) |
| AU (1) | AU780459B2 (zh) |
| BR (1) | BR0016253A (zh) |
| CA (1) | CA2397583C (zh) |
| CZ (1) | CZ20021983A3 (zh) |
| DE (1) | DE60015796T2 (zh) |
| DK (1) | DK1240172T3 (zh) |
| EE (1) | EE05067B1 (zh) |
| ES (1) | ES2230174T3 (zh) |
| HK (2) | HK1048321B (zh) |
| HU (1) | HUP0300301A3 (zh) |
| IL (2) | IL149840A0 (zh) |
| IS (1) | IS2231B (zh) |
| MX (1) | MXPA02005536A (zh) |
| MY (1) | MY125414A (zh) |
| NO (1) | NO329595B1 (zh) |
| NZ (1) | NZ519376A (zh) |
| PL (1) | PL201789B1 (zh) |
| PT (1) | PT1240172E (zh) |
| RU (1) | RU2260595C2 (zh) |
| SE (1) | SE9904508D0 (zh) |
| SI (1) | SI1240172T1 (zh) |
| SK (1) | SK286904B6 (zh) |
| TW (1) | TWI228510B (zh) |
| UA (1) | UA71649C2 (zh) |
| WO (1) | WO2001042252A1 (zh) |
| ZA (1) | ZA200204127B (zh) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| US7319095B2 (en) * | 1999-12-09 | 2008-01-15 | Astrazeneca Ab | Use of GABAB receptor agonists |
| WO2002062324A2 (en) * | 2001-02-05 | 2002-08-15 | Michael Albert Kamm | A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| AR033779A1 (es) * | 2001-06-08 | 2004-01-07 | Astrazeneca Ab | Compuestos utiles en la enfermedad de reflujo |
| SE0201940D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination II |
| SE0201939D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination |
| SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
| WO2006050471A2 (en) | 2004-11-03 | 2006-05-11 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
| US7494985B2 (en) | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| US20060160777A1 (en) * | 2004-12-27 | 2006-07-20 | Anders Lehmann | New use of GABAbeta receptor agonists |
| WO2007073300A1 (en) | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Gaba-b receptor modulators |
| JP2009521428A (ja) | 2005-12-23 | 2009-06-04 | アストラゼネカ・アクチエボラーグ | 胃腸疾患治療用のイミダゾール誘導体 |
| US7585996B2 (en) | 2006-09-15 | 2009-09-08 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| ATE528310T1 (de) | 2007-05-04 | 2011-10-15 | Astrazeneca Ab | Verfahren zur synthese von alkylphosphinsäuren durch initiierung eines amins und eines aminoxids |
| JP2010534239A (ja) * | 2007-07-25 | 2010-11-04 | アストラゼネカ・アクチエボラーグ | Ｎｅｒｄの治療のための（３−アミノ−２−フルオロプロピル）ホスフィン酸の使用 |
| EP2235026A4 (en) * | 2007-12-21 | 2011-08-17 | Astrazeneca Ab | NEW PROCESS FOR THE PREPARATION OF (2R) - (3-AMINO-2-FLUORO-PROPYL) PHOSPHIC ACID FORM A |
| PE20091176A1 (es) * | 2007-12-21 | 2009-09-03 | Astrazeneca Ab | Nueva forma cristalina c del acido (2r)-(3-amino-2-fluoropropil)fosfinico |
| US20110034420A1 (en) * | 2007-12-21 | 2011-02-10 | Ida Hoyer | Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| WO2009145716A1 (en) * | 2008-05-28 | 2009-12-03 | Astrazeneca Ab | New pharmaceutical formulation useful in gerd therapy |
| WO2010051883A1 (de) | 2008-11-05 | 2010-05-14 | Clariant International Ltd | Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels allylalkoholen/acroleinen und ihre verwendung |
| WO2010051893A1 (de) | 2008-11-07 | 2010-05-14 | Clariant International Ltd | Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels acrylsäurederivaten und ihre verwendung |
| DE102008056341A1 (de) | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung |
| JP5743219B2 (ja) | 2008-11-11 | 2015-07-01 | クラリアント・ファイナンス・（ビーブイアイ）・リミテッド | アリル化合物を用いる、モノアリル官能性ジアルキルホスフィン酸、それらの塩およびエステルの製造方法およびそれらの使用 |
| DE102008060035A1 (de) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung |
| DE102008060535A1 (de) | 2008-12-04 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung |
| DE102008063668A1 (de) | 2008-12-18 | 2010-07-01 | Clariant International Limited | Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung |
| DE102008063642A1 (de) | 2008-12-18 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung |
| DE102008063627A1 (de) * | 2008-12-18 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung |
| KR101697948B1 (ko) | 2008-12-18 | 2017-01-19 | 클라리언트 파이넌스 (비브이아이)리미티드 | 아세틸렌을 사용하는 에틸렌디알킬포스핀산, 에틸렌디알킬포스핀산 에스테르 및 에틸렌디알킬포스핀산 염의 제조방법 및 이의 용도 |
| DE102008064003A1 (de) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| WO2012009646A1 (en) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH449046A (de) | 1963-07-09 | 1967-12-31 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
| GB8425872D0 (en) | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| AU594424B2 (en) | 1986-01-03 | 1990-03-08 | University Of Melbourne, The | Gastro-oesophageal reflux composition |
| US4740332A (en) * | 1986-05-12 | 1988-04-26 | E. R. Squibb & Sons, Inc. | Process for preparing phosphonous acids |
| GB8820266D0 (en) | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| US5567840A (en) | 1989-05-13 | 1996-10-22 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| GB8911017D0 (en) | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| US5281747A (en) | 1989-05-13 | 1994-01-25 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| US5006560A (en) | 1989-12-20 | 1991-04-09 | Schering Corporation | Use of GABA-B selective agonists as anti-tussive agents |
| IL98502A (en) * | 1990-06-22 | 1998-04-05 | Ciba Geigy Ag | History of Aminoalkene Phosphine Acid, Process for Their Preparation and Pharmaceutical Preparations Containing Them |
| FR2663934B1 (fr) | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| GB9125615D0 (en) * | 1991-12-02 | 1992-01-29 | Wyeth John & Brother Ltd | Amines |
| AU662404B2 (en) * | 1992-05-08 | 1995-08-31 | Novartis Ag | Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids |
| FR2722192A1 (fr) | 1994-07-06 | 1996-01-12 | Adir | Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9420784D0 (en) | 1994-10-14 | 1994-11-30 | Glaxo Group Ltd | Medicaments |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| SE9904507D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| US7319095B2 (en) * | 1999-12-09 | 2008-01-15 | Astrazeneca Ab | Use of GABAB receptor agonists |
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
-
1999
- 1999-12-09 SE SE9904508A patent/SE9904508D0/xx unknown
-
2000
- 2000-04-12 UA UA2002064507A patent/UA71649C2/uk unknown
- 2000-11-27 TW TW089125135A patent/TWI228510B/zh not_active IP Right Cessation
- 2000-12-04 AR ARP000106418A patent/AR030541A1/es active IP Right Grant
- 2000-12-04 CZ CZ20021983A patent/CZ20021983A3/cs unknown
- 2000-12-04 BR BR0016253-1A patent/BR0016253A/pt not_active IP Right Cessation
- 2000-12-04 MX MXPA02005536A patent/MXPA02005536A/es active IP Right Grant
- 2000-12-04 US US09/786,219 patent/US6576626B2/en not_active Expired - Fee Related
- 2000-12-04 ES ES00983634T patent/ES2230174T3/es not_active Expired - Lifetime
- 2000-12-04 RU RU2002113909/04A patent/RU2260595C2/ru not_active IP Right Cessation
- 2000-12-04 IL IL14984000A patent/IL149840A0/xx active IP Right Grant
- 2000-12-04 EE EEP200200286A patent/EE05067B1/xx not_active IP Right Cessation
- 2000-12-04 DK DK00983634T patent/DK1240172T3/da active
- 2000-12-04 SI SI200030561T patent/SI1240172T1/xx unknown
- 2000-12-04 PL PL364795A patent/PL201789B1/pl not_active IP Right Cessation
- 2000-12-04 AT AT00983634T patent/ATE282043T1/de active
- 2000-12-04 DE DE60015796T patent/DE60015796T2/de not_active Expired - Lifetime
- 2000-12-04 WO PCT/SE2000/002426 patent/WO2001042252A1/en active IP Right Grant
- 2000-12-04 KR KR1020027007355A patent/KR100689144B1/ko not_active IP Right Cessation
- 2000-12-04 SK SK764-2002A patent/SK286904B6/sk not_active IP Right Cessation
- 2000-12-04 EP EP04021533A patent/EP1484333A1/en not_active Withdrawn
- 2000-12-04 JP JP2001543550A patent/JP3914435B2/ja not_active Expired - Fee Related
- 2000-12-04 EP EP00983634A patent/EP1240172B1/en not_active Expired - Lifetime
- 2000-12-04 CN CNB008168989A patent/CN1198832C/zh not_active Expired - Fee Related
- 2000-12-04 PT PT00983634T patent/PT1240172E/pt unknown
- 2000-12-04 CA CA2397583A patent/CA2397583C/en not_active Expired - Fee Related
- 2000-12-04 HU HU0300301A patent/HUP0300301A3/hu unknown
- 2000-12-04 NZ NZ519376A patent/NZ519376A/en not_active IP Right Cessation
- 2000-12-04 AU AU20364/01A patent/AU780459B2/en not_active Ceased
- 2000-12-07 MY MYPI20005746A patent/MY125414A/en unknown
-
2002
- 2002-05-23 ZA ZA200204127A patent/ZA200204127B/xx unknown
- 2002-06-06 IS IS6408A patent/IS2231B/is unknown
- 2002-06-07 NO NO20022728A patent/NO329595B1/no not_active IP Right Cessation
-
2003
- 2003-01-17 HK HK03100457.3A patent/HK1048321B/zh not_active IP Right Cessation
- 2003-04-04 US US10/406,838 patent/US6841698B2/en not_active Expired - Fee Related
- 2003-07-29 HK HK03105473A patent/HK1053125A1/xx not_active IP Right Cessation
-
2004
- 2004-01-01 IL IL149840A patent/IL149840A/en not_active IP Right Cessation
- 2004-12-16 US US11/016,543 patent/US7034176B2/en not_active Expired - Fee Related
-
2006
- 2006-04-07 US US11/400,021 patent/US7807658B2/en not_active Expired - Fee Related
- 2006-06-27 JP JP2006175983A patent/JP2006306885A/ja active Pending
-
2007
- 2007-07-12 US US11/776,648 patent/US20080146836A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0300301A3 (en) | New aminopropylphosphinic acids | |
| DE50002490D1 (en) | Polyester-polyetherblockcopolymere | |
| PL348244A1 (en) | Substituted indolealkanoic acids | |
| DE50008011D1 (en) | Thixotropierungsmittel | |
| DE50002614D1 (en) | Sigma-delta-modulator | |
| IL148218A0 (en) | New phenylpiperazines | |
| DE60007505D1 (en) | Propargyletherderivate | |
| HUP0202384A3 (en) | Substituted phenoxyacetic acids | |
| DE50000137D1 (en) | Spirofluorenopyrane | |
| DE59909975D1 (en) | Testleck | |
| AU1497802A (en) | Ss-thio-amino acids | |
| DE60001313D1 (en) | Imidazodiazepinderivate | |
| DE10081629D2 (en) | Seilzugbefestigung | |
| DE50009469D1 (en) | Common-rail-injektor | |
| DE50010757D1 (en) | Stilbenaufheller | |
| DE50008218D1 (en) | Common-rail-injektor | |
| DE50012999D1 (en) | Stirnwandisolation | |
| GB9905235D0 (en) | Connection | |
| DE60004080D1 (en) | Centroidintegration | |
| AU141428S (en) | Turnpiece | |
| DE50012739D1 (en) | Thermovliesstoff | |
| DE50008219D1 (en) | Common-rail-injektor | |
| DE50005334D1 (en) | Tricyclische benzoylcyclohexandion-derivate | |
| DE60004674D1 (en) | Carbonylierungsreaktionen | |
| DE50005597D1 (en) | Laryngoskop |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHRG | Changes in the register |
Free format text: DELETION OF INVENTOR: ANDERS HOLMEN; THOMAS OLSSON |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121204 |